NCT03542123View on ClinicalTrials.gov

Cardiac Output Autonomic Stimulation Therapy for Heart Failure - Hemodynamic Effects

NAUnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 5, 2018

Primary Completion Date

June 1, 2019

Study Completion Date

July 1, 2019

Conditions
Heart Failure AcuteHeart Failure
Interventions
DEVICE

NeuroTronik CANS Therapy® System

The NeuroTronik CANS Therapy® System is a percutaneous, catheter-based, bedside electrical stimulation system. The System consists of the single-use, disposable NeuroCatheter™ and NeuroCatheter™ Placement Kit, along with the reusable, bedside NeuroModulator™ Development System, and the NeuroTronik CANS Therapy™ Cable.

Trial Locations (1)

Unknown

RECRUITING

Sanatorio Italiano, Asunción

Sponsors

Lead Sponsor

NeuroTronik Inc.
All Listed Sponsors
lead

NeuroTronik Inc.

INDUSTRY